Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00360828 |
|---|---|
| Brief Title: | Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas |
| First Submitted : | August 3, 2006 |
| First Submitted that Met QC Criteria : | August 3, 2006 |
| First Posted : | August 7, 2006 (Estimate) |
| Results First Submitted : | October 3, 2011 |
| Results First Submitted that Met QC Criteria : | November 7, 2011 |
| Results First Posted : | December 9, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 20, 2017 |
| Last Update Posted : | March 23, 2017 |